[Pharmacokinetic of antibiotics in patients with mucoviscidosis (author's transl)].
Inadequate therapeutic results in the treatment of bacterial infections in patients with Cystic Fibrosis prompted a reevaluation of pharmacokinetic parameters of orally and parenterally administered drugs in these patients. Gentamicin, Azlocillin and Ticarcillin are eliminated faster in patients with Cystic Fibrosis. Serum concentrations show a rapid decrease over 60 to 90 minutes and surpass MIC values of Pseudomonas isolates for a maximum of only 60 minutes. 70% to 90% of the administered amount of drug is eliminated within two hours in the urine. Concomitantly determined clearance rates for creatinine didn't show abnormalities, however they pointed towards an additional tubular secretion of Gentamicin which is not seen in healthy controls. Cephalexin, Epicillin and both components of Cotrimoxazol show a delay in oral absorption. The renal elimination of Cephalexin and Trimethoprim is unaltered, but the excretion of Epicillin and Sulfametrol is enhanced again. This is seen by a delay and decrease in the maximal serum concentration (Cmax), but increased urine recovery. Doubling of the dose of gentamicin administered as i. v. infusion over 45 to 60 minutes results in smooth serum curve, the MIC values of most encountered organisms are surpassed for 3 hours and more. The clinical applicability of this recommendation however awaits further investigations concerning efficacy and safety.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000097:blood*; D001390:Azlocillin; D002648:Child; D003550:Cystic Fibrosis / Q000097:blood*; D005839:Gentamicins / Q000097:blood; D006801:Humans; D008657:Metabolic Clearance Rate; D010406:Penicillins / Q000097:blood; D013424:Sulfanilamides / Q000097:blood; D013982:Ticarcillin / Q000097:blood; D014295:Trimethoprim / Q000097:blood
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D013424:Sulfanilamides; D014295:Trimethoprim; C012047:sulfametrole; D013982:Ticarcillin; D001390:Azlocillin
Pharmakokinetik von Antibiotika bei Patienten mit Mukoviszidose.